Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap321.40M
Enterprise Value301.54M
IRD
(NASDAQ)Opus Genetics, Inc.
$4.55-- (--)
Loading... - Market loading
Opus Genetics (IRD) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)22.64
Forward Price/Sales12.97
Price/Book (mrq)55.52
Price/Tangible Book (mrq)55.52
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue20.61
EV/Earnings-4.42
EV/EBITDA-4.42
EV/EBIT-4.42
Stock Price
Current price, 52-week range, and moving averages
Current Price$4.55
1-Day Change3.08%
52-Week High$5.30
52-Week Low$0.65
52-Week Change415.38%
YTD Change121.23%
1-Year Change402.90%
50-Day MA$3.81
200-Day MA$2.17
Avg Volume (30 day)346.86K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding70.64M
Book Value per Share$0.08
Net Cash per Share$0.44
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$11.60
Target Upside/Downside154.95%
Analyst ConsensusStrong Buy
Analyst Count5
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin5.60%
EBITDA Margin (ttm)-466.06%
EBIT Margin (ttm)-466.40%
Operating Margin (ttm)-254.05%
Pretax Margin (ttm)-466.09%
Profit Margin (ttm)-466.09%
FCF Margin (ttm)-225.23%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)-1143.00%
Return on Assets (ttm)-188.81%
Return on Capital Employed (ttm)-970.14%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue14.63M
Gross Profit820.00K
Operating Income-37.17M
Pretax Income-68.20M
Net Income-68.20M
EBITDA-68.20M
EBIT-68.25M
Diluted EPS$-0.97
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow-32.86M
Growth Rates (YoY)
Year-over-year growth metrics
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)36.12M
Cash & Securities (mrq)30.82M
Net Cash (mrq)30.82M
Net Cash per Share$0.44
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)1.07M
Working Capital (mrq)6.82M
Total Equity (mrq)5.97M
Book Value per Share$0.08
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)1.23
Quick Ratio (mrq)1.23
Debt/Equity (mrq)0.18
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield-20.59%
Buyback Yield0.00%
Total Shareholder Yield0.00%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-5.68
Piotroski F-Score2/9
Frequently Asked Questions About Opus Genetics Statistics
What are the key financial metrics for IRD?
Opus Genetics, Inc. (IRD) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is IRD's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Opus Genetics is overvalued or undervalued.
How do I read IRD's profitability ratios?
Opus Genetics's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do IRD's debt ratios indicate?
The financial health section shows Opus Genetics's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is IRD's dividend analysis?
The dividend section covers Opus Genetics's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.